相关实验视频
Updated: Jan 16, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
对肝纤维化后翻译性修饰的机制性见解:致病作用和治疗潜力
Xiwen Bai1,2, Zhihan Liu3, Xianbin Li1,2
1Department of Infectious Diseases, State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China.
这项研究强调了九种转化后修饰 (PTM) 在肝纤维化中的作用. 它还审查了六种针对这些PTM的药物类别,以寻找治疗肝纤维化治疗的潜在治疗益处.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝纤维化是肝病的显著进展,其特征是星状细胞激活和细胞外矩阵积累.
- 肝纤维化背后的复杂机制需要进一步研究.
- 翻译后修饰 (PTMs) 越来越多地被认为在肝纤维化病变发生过程中发挥着关键作用.
研究的目的:
- 探索9个特定的PTMs在肝纤维化中的参与.
- 审查六种针对PTM治疗肝纤维化的药物类别的治疗潜力.
主要方法:
- 文献综述和对肝纤维化中PTMs现有研究的分析.
- 检查药物类别,包括ACC抑制剂,ASK1抑制剂,Akt激活剂,FXR激动剂,PTP1B抑制剂和HDAC抑制剂.
主要成果:
- 九种PTM (甲基化,乙化,SUMOylation,Neddylation,化,克罗化,糖化,乳化和无处不在化) 都与肝纤维化有关.
- 几种药物类别在针对这些PTM进行治疗干预方面表现有前途.
结论:
- 肝纤维素在肝纤维化的发展和进展中起着关键作用.
- 针对特定药物类别的PTM是一种有前途的肝纤维化治疗策略.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

